BACKGROUND: Published studies of the association between serum potassium concentration and risk for cardiovascular disease in community-based populations have reported conflicting results. We sought to determine the association between serum potassium concentration and cardiovascular disease risk in the Framingham Heart Study. METHODS: A total of 3151 participants (mean age, 43 years; 48% men) in the Framingham Heart Study who were free of cardiovascular disease and not taking medications affecting potassium homeostasis had serum potassium levels measured (1979-1983). Proportional hazards models were used to determine the association of serum potassium concentration at baseline with the incidence of cardiovascular disease at follow-up. RESULTS: During mean follow-up of 16 years, 313 cardiovascular disease events occurred, including 46 cardiovascular disease-related deaths. After adjustment for age, serum potassium level was marginally associated with risk of cardiovascular disease (hazard ratio [HR] per 1 mg/dL increment, 1.03; 95% confidence interval [CI], 1.00-1.05; P =.02). However, after further adjustment for multiple confounders, serum potassium level was not significantly associated with cardiovascular disease risk (HR, 1.00; 95% CI, 0.98-1.03). There were no significant associations between serum potassium level and cardiovascular disease-related death in either age- and sex-adjusted models (HR, 1.06; 95% CI, 0.99-1.12) or multivariable-adjusted models (HR, 1.04; 95% CI, 0.97-1.11). CONCLUSION: In our community-based sample of individuals free of cardiovascular disease and not taking medications that affect potassium homeostasis, serum potassium level was not associated with risk of cardiovascular disease.
BACKGROUND: Published studies of the association between serum potassium concentration and risk for cardiovascular disease in community-based populations have reported conflicting results. We sought to determine the association between serum potassium concentration and cardiovascular disease risk in the Framingham Heart Study. METHODS: A total of 3151 participants (mean age, 43 years; 48% men) in the Framingham Heart Study who were free of cardiovascular disease and not taking medications affecting potassium homeostasis had serum potassium levels measured (1979-1983). Proportional hazards models were used to determine the association of serum potassium concentration at baseline with the incidence of cardiovascular disease at follow-up. RESULTS: During mean follow-up of 16 years, 313 cardiovascular disease events occurred, including 46 cardiovascular disease-related deaths. After adjustment for age, serum potassium level was marginally associated with risk of cardiovascular disease (hazard ratio [HR] per 1 mg/dL increment, 1.03; 95% confidence interval [CI], 1.00-1.05; P =.02). However, after further adjustment for multiple confounders, serum potassium level was not significantly associated with cardiovascular disease risk (HR, 1.00; 95% CI, 0.98-1.03). There were no significant associations between serum potassium level and cardiovascular disease-related death in either age- and sex-adjusted models (HR, 1.06; 95% CI, 0.99-1.12) or multivariable-adjusted models (HR, 1.04; 95% CI, 0.97-1.11). CONCLUSION: In our community-based sample of individuals free of cardiovascular disease and not taking medications that affect potassium homeostasis, serum potassium level was not associated with risk of cardiovascular disease.
Authors: Jan M Hughes-Austin; Dena E Rifkin; Tomasz Beben; Ronit Katz; Mark J Sarnak; Rajat Deo; Andrew N Hoofnagle; Shunichi Homma; David S Siscovick; Nona Sotoodehnia; Bruce M Psaty; Ian H de Boer; Bryan Kestenbaum; Michael G Shlipak; Joachim H Ix Journal: Clin J Am Soc Nephrol Date: 2017-01-31 Impact factor: 8.237
Authors: Michael H Alderman; Linda B Piller; Charles E Ford; Jeffrey L Probstfield; Suzanne Oparil; William C Cushman; Paula T Einhorn; Stanley S Franklin; Vasilios Papademetriou; Stephen T Ong; John H Eckfeldt; Curt D Furberg; David A Calhoun; Barry R Davis Journal: Hypertension Date: 2012-03-19 Impact factor: 10.190
Authors: Ali Ahmed; Faiez Zannad; Thomas E Love; Jose Tallaj; Mihai Gheorghiade; Olaniyi James Ekundayo; Bertram Pitt Journal: Eur Heart J Date: 2007-06 Impact factor: 29.983
Authors: Ragnhild S Falk; Trude Eid Robsahm; Jan Erik Paulsen; Tanja Stocks; Isabel Drake; Trond Heir Journal: BMC Public Health Date: 2021-04-13 Impact factor: 3.295